Enter your email address in the box to the right of this page to receive email updates from the Life Sciences Hub when new content is published.
For those with an interest in life sciences, the rise to prominence of CRISPR, a transformational development in the field of molecular biology and genetics, has been impossible to ignore.
In this paper we consider how a new generation of VR equipment promises to fundamentally change consumer experiences of virtual environments, including in the Life Sciences sector.
A rapidly-changing cybersecurity risk landscape for Life Sciences companies.
Welcome to our blog dedicated to Life Sciences. We report on EU and national regulatory, compliance, intellectual property and transactional developments in the sector. We focus on (bio)pharmaceuticals and medical technologies, and also cover food and beverages, cosmetics and other healthcare products.
12 October 2017 - Posted by: Iradj Nazaryar
On 31 August 2017, the Dutch Ministry of Health published Policy Rules providing guidance on the ban on inducements, which was introduced by the amendment of the Dutch Medical Devices Act of 17 May 2017. The amendment establishes a prohibition on inducements, whether in cash or in kind, offered by medical device suppliers to professionals › Read More
10 October 2017 - Posted by: Tine Carmeliet
On 6 September 2017, the website of the BeNeLuxA collaboration, beneluxa.org, was officially launched (see Belgian and Dutch government press releases). The BeNeLuxA collaboration is an initiative between Belgium, the Netherlands, Luxembourg and Austria on pharmaceutical policy that aims to ensure sustainable and affordable access to innovative medicines (in particular, orphan drugs) by levelling the › Read More
05 October 2017 - Posted by: Matthew Appleton
Continued uncertainty surrounding President Trump’s proposed tax reforms has slowed activity in the Life Sciences sector, with deal values holding well below the record levels seen in previous years. If Trump’s promised corporate tax cut materialises, big U.S. players may be encouraged to repatriate (and spend) the huge amounts of cash currently held offshore. But › Read More
04 October 2017 - Posted by: Jacqueline Bore
On Saturday, the European Commission (EC) published its assessment of the bids by 19 Member States to host the European Medicines Agency (EMA) when it relocates from London in March 2019. As instructed by the Member States, the EC has been careful to avoid betraying any preference by producing a ranking or short list. The › Read More
02 October 2017 - Posted by: William Palmer
In a joint letter to the negotiators representing the UK and EU, medical device and in vitro diagnostic industry trade groups have urged both parties to ensure full regulatory implementation in their sector following “Brexit”, in March 2019. The trade groups represented are MedTech Europe (MedTech), the Association of British Healthcare Industries (ABHI) and the › Read More